scholarly journals Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections

Viruses ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 596
Author(s):  
Karin Stiasny ◽  
Stefan Malafa ◽  
Stephan W. Aberle ◽  
Iris Medits ◽  
Georgios Tsouchnikas ◽  
...  

Flaviviruses circulate worldwide and cause a number of medically relevant human diseases, such as dengue, Zika, yellow fever, and tick-borne encephalitis (TBE). Serology plays an important role in the diagnosis of flavivirus infections, but can be impeded by antigenic cross-reactivities among flaviviruses. Therefore, serological diagnosis of a recent infection can be insufficiently specific, especially in areas where flaviviruses co-circulate and/or vaccination coverage against certain flaviviruses is high. In this study, we developed a new IgM assay format, which is well suited for the specific diagnosis of TBE, Zika and dengue virus infections. In the case of TBE and Zika, the IgM response proved to be highly specific for the infecting virus. In contrast, primary dengue virus infections induced substantial amounts of cross-reactive IgM antibodies, which is most likely explained by structural peculiarities of dengue virus particles. Despite the presence of cross-reactive IgM, the standardized nature and the quantitative read-out of the assay even allowed the serotype-specific diagnosis of recent dengue virus infections in most instances.

2016 ◽  
Vol 21 (16) ◽  
Author(s):  
Daniela Huzly ◽  
Ingeborg Hanselmann ◽  
Jonas Schmidt-Chanasit ◽  
Marcus Panning

The current Zika virus (ZIKV) epidemic in the Americas caused an increase in diagnostic requests in European countries. Here we demonstrate high specificity of the Euroimmun anti-ZIKV IgG and IgM ELISA tests using putative cross-reacting sera of European patients with antibodies against tick-borne encephalitis virus, dengue virus, yellow fever virus and hepatitis C virus. This test may aid in counselling European travellers returning from regions where ZIKV is endemic.


Author(s):  
К.К. Тучинская ◽  
В.П. Волок ◽  
В.В. Илларионова ◽  
О.И. Ковалева

Вирус клещевого энцефалита (ВКЭ) является возбудителем тяжелого неврологического заболевания человека и широко распространен на территории Евразии. При репродукции флавивирусов помимо инфекционных вирионов накапливается набор неинфекционных вирусных структур: незрелые формы вирионов, пустые формы (не содержащие геном вирусные частицы), а также агрегаты поверхностного белка Е, способные оказывать влияние на иммунный ответ, и патогенез. Штаммы ВКЭ могут различаться по соотношению этих форм в инфекционном материале, т.е. по характеру структурной гетерогенности. Цель: подобрать комплекс методов, способных выявить данные различия. Методы. Общую концентрацию белка Е определяли методом ИФА, число частиц, содержащих геном (ГСЧ) - ПЦР в реальном времени, а для выявления инфекционных вирусных частиц - титрование в культуре клеток. Результаты. Разработан метод оценки структурной гетерогенности популяции ВКЭ. Было показано, что повышенное содержание неинфекционных вирусных частиц, содержащих геном, и несвязанных с ними белка Е не зависит от подтипа вируса. Выводы. Штаммы ВКЭ отличились по соотношению общего числа ГСЧ к числу инфекционных вирионов и по содержанию белка Е, связанного и несвязанного с ГСЧ. Tick-borne encephalitis virus (TBEV) is widespread in Europe and Asia and causes severe neurological disease in humans. It has been established that the reproduction of flaviviruses leads to the accumulation of a whole set of non-infectious viral structures aside from infectious virions. These structures include immature virions, empty forms (containing no genome) and aggregates of the surface protein E. These structures, despite being non-infectious, are able to influence the immune response and, consequently, the pathogenesis of TBEV infection. The aim of this work was to select a set of methods which can be implemented to identify these differences. Methods. Virus samples were analised for protein E concentration, number of genome-containing particles and infectivity. The total concentration of protein E in samples was evaluated using ELISA. The number of genome-containing particles was determined by a real-time PCR, and to assess the number of infectious virus particles titration in PEK cell culture was used. Results. An assay for total concentration of protein E in culture fluid of cells infected with different strains of TBEV based on the commertially available ELISA kit was developed. TBEV strains used in the study varied by the ratio of genome-containing particles to infectious virions. The amount of protein E not associated with genome-containing virions was calculated as a difference between total content of protein E and the amount of protein E bound to genome-containing particles. This amount was also different for studied samples of TBEV strains. Conclusion. No correlation was observed between the increased content of non-infectious genome-containing particles or the amount of residual protein E and TBEV subtypes.


PLoS ONE ◽  
2019 ◽  
Vol 14 (10) ◽  
pp. e0224044
Author(s):  
Johannes P. Borde ◽  
Klaus Kaier ◽  
Philip Hehn ◽  
Merle M. Böhmer ◽  
Teresa M. Kreusch ◽  
...  

2020 ◽  
Vol 28 ◽  
pp. 204020662094346
Author(s):  
Evgenia V Dueva ◽  
Ksenia K Tuchynskaya ◽  
Liubov I Kozlovskaya ◽  
Dmitry I Osolodkin ◽  
Kseniya N Sedenkova ◽  
...  

Tick-borne encephalitis is an important human arbovirus neuroinfection spread across the Northern Eurasia. Inhibitors of tick-borne encephalitis virus (TBEV) strain Absettarov, presumably targeting E protein n-octyl-β-d-glucoside (β-OG) pocket, were reported earlier. In this work, these inhibitors were tested in vitro against seven strains representing three main TBEV subtypes. The most potent compound, 2-[(2-methyl-1-oxido-5,6,7,8-tetrahydroquinazolin-4-yl)amino]-phenol, showed EC50 values lower than 22 µM against all the tested strains. Nevertheless, EC50 values for virus samples of certain strains demonstrated a substantial variation, which appeared to be consistent with the presence of E protein not only in infectious virions, but also in non-infectious and immature virus particles, protein aggregates, and membrane complexes.


2005 ◽  
Vol 37 (10) ◽  
pp. 742-746 ◽  
Author(s):  
Aurita Juceviciene ◽  
Milda Zygutiene ◽  
Pauli Leinikki ◽  
Henrikki Brummer-Korvenkontio ◽  
Mika Salminen ◽  
...  

mSphere ◽  
2018 ◽  
Vol 3 (1) ◽  
Author(s):  
James Duehr ◽  
Silviana Lee ◽  
Gursewak Singh ◽  
Gregory A. Foster ◽  
David Krysztof ◽  
...  

ABSTRACT Recent reports in the scientific literature have suggested that anti-dengue virus (DENV) and anti-West Nile virus (WNV) immunity exacerbates Zika virus (ZIKV) pathogenesis in vitro and in vivo in mouse models. Large populations of immune individuals exist for a related flavivirus (tick-borne encephalitis virus [TBEV]), due to large-scale vaccination campaigns and endemic circulation throughout most of northern Europe and the southern Russian Federation. As a result, the question of whether anti-TBEV immunity can affect Zika virus pathogenesis is a pertinent one. For this study, we obtained 50 serum samples from individuals vaccinated with the TBEV vaccine FSME-IMMUN (Central European/Neudörfl strain) and evaluated their enhancement capacity in vitro using K562 human myeloid cells expressing CD32 and in vivo using a mouse model of ZIKV pathogenesis. Among the 50 TBEV vaccinee samples evaluated, 29 had detectable reactivity against ZIKV envelope (E) protein by enzyme-linked immunosorbent assay (ELISA), and 36 showed enhancement of ZIKV infection in vitro. A pool of the most highly reacting and enhanced samples resulted in no significant change in the morbidity/mortality of ZIKV disease in immunocompromised Stat2−/− mice. Our results suggest that humoral immunity against TBEV is unlikely to enhance Zika virus pathogenesis in humans. No clinical reports indicating that TBEV vaccinees experiencing enhanced ZIKV disease have been published so far, and though the epidemiological data are sparse, our findings suggest that there is little reason for concern. This study also displays a clear relationship between the phylogenetic distance between two flaviviruses and their capacity for pathogenic enhancement. IMPORTANCE The relationship between serial infections of two different serotypes of dengue virus and more severe disease courses is well-documented in the literature, driven by so-called antibody-dependent enhancement (ADE). Recently, studies have shown the possibility of ADE in cells exposed to anti-DENV human plasma and then infected with ZIKV and also in mouse models of ZIKV pathogenesis after passive transfer of anti-DENV human plasma. In this study, we evaluated the extent to which this phenomenon occurs using sera from individuals immunized against tick-borne encephalitis virus (TBEV). This is highly relevant, since large proportions of the European population are vaccinated against TBEV or otherwise seropositive.


2020 ◽  
Vol 65 (1) ◽  
pp. 21-26 ◽  
Author(s):  
A. P. Ivanov ◽  
T. D. Klebleeva ◽  
O. E. Ivanova

Introduction. The well-known advantages of class Y antibodies (IgY) from egg yolks of immunized hens in comparison with class G antibodies (IgG) of laboratory animals traditionally used in laboratory diagnosis of infectious diseases determine the stable interest of researchers in using IgY for these purposes (IgY technology) . Over the past 20 years, the obvious benefits of IgY technology have been demonstrated for a number of viral and bacterial infections. Goals and objectives. Construction of ELISA systems based on specific IgY for laboratory diagnosis of infections caused by tick-borne encephalitis virus, yellow fever virus, poliovirus.Material and methods. Obtaining yolk preparations of immunized chickens, obtaining highly purified IgY preparations (salting out, affinity chromatography), constructing ELISA systems for determining virus-specific antigens, testing the parameters of ELISA systems.Results and discussion. For the first time in laboratory practice, ELISA systems based on the use of specific polyclonal IgY were designed for laboratory diagnosis of topical human viral infections caused by flaviviruses and enteroviruses: determination of antigens of tick-borne encephalitis virus, yellow fever virus, 3 types of poliovirus. It was experimentally shown that these ELISA systems have high sensitivity and specificity, which allows them to be used for the semiquantitative and quantitative determination of antigens of these viruses in various materials (infected cell cultures, vaccines, etc.).Conclusion. The ELISA systems developed on the basis of specific IgY for determination of viral antigens can be effectively used for laboratory diagnosis of a number of viral infections, for the validation and control of vaccine preparations.


2019 ◽  
Vol 20 (3) ◽  
pp. 691 ◽  
Author(s):  
Maja Potokar ◽  
Jernej Jorgačevski ◽  
Robert Zorec

Virus infections of the central nervous system (CNS) can manifest in various forms of inflammation, including that of the brain (encephalitis) and spinal cord (myelitis), all of which may have long-lasting deleterious consequences. Although the knowledge of how different viruses affect neural cells is increasing, understanding of the mechanisms by which cells respond to neurotropic viruses remains fragmented. Several virus types have the ability to infect neural tissue, and astrocytes, an abundant and heterogeneous neuroglial cell type and a key element providing CNS homeostasis, are one of the first CNS cell types to get infected. Astrocytes are morphologically closely aligned with neuronal synapses, blood vessels, and ventricle cavities, and thereby have the capacity to functionally interact with neurons and endothelial cells. In this review, we focus on the responses of astrocytes to infection by neurotropic flaviviruses, including tick-borne encephalitis virus (TBEV), Zika virus (ZIKV), West Nile virus (WNV), and Japanese encephalitis virus (JEV), which have all been confirmed to infect astrocytes and cause multiple CNS defects. Understanding these mechanisms may help design new strategies to better contain and mitigate virus- and astrocyte-dependent neuroinflammation.


Marine Drugs ◽  
2018 ◽  
Vol 16 (12) ◽  
pp. 509 ◽  
Author(s):  
Sergey Fedoreyev ◽  
Natalia Krylova ◽  
Natalia Mishchenko ◽  
Elena Vasileva ◽  
Evgeny Pislyagin ◽  
...  

The aim of this study was to examine the in vitro antioxidant and antiviral activities of echinochrome A and echinochrome-based antioxidant composition against tick-borne encephalitis virus (TBEV) and herpes simplex virus type 1 (HSV-1). The antioxidant composition, which is a mixture of echinochrome A, ascorbic acid, and α-tocopherol (5:5:1), showed higher antioxidant and antiviral effects than echinochrome A. We suppose that echinochrome A and its composition can both directly affect virus particles and indirectly enhance antioxidant defense mechanisms in the hosting cell. The obtained results allow considering the echinochrome A and the composition of antioxidants on its basis as the promising agents with the both antioxidant and antiviral activities.


Sign in / Sign up

Export Citation Format

Share Document